NCT02445690

Brief Summary

One hundred and fifty patients with Crohn's disease involving the terminal ileum or the colon, in clinical remission, with or without endoscopic activity will be included. Thrombin generation will be measured and correlated with the simplified endoscopic activity score. The patients will be evaluated for development of deep vein thrombosis after one-year of follow-up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2015

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

May 12, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 15, 2015

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

May 12, 2016

Status Verified

May 1, 2015

Enrollment Period

1.9 years

First QC Date

May 12, 2015

Last Update Submit

May 11, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation between thrombin generation and endoscopic activity

    At the moment of the inclusion

Secondary Outcomes (1)

  • Association of a high thrombin generation and development of deep vein thrombosis

    After 1 year of follow up

Study Arms (2)

Clinical remission without inflammation

Patients with Crohn's disease in clinical remission and no inflammation in the colonoscopy

Clinical remission with inflammation

Patients with Crohn's disease in clinical remission and active inflammation in the colonoscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with established Crohn's disease with stable treatment and clinical remission

You may qualify if:

  • Established Crohn's disease diagnosis for at least 6 months
  • Disease involvement of the terminal ileum and/or colon
  • Clinical remission
  • Stable treatment for at least 3 months

You may not qualify if:

  • Colectomy
  • Neoplasia
  • Surgery in the last 6 months
  • Anticoagulant treatment
  • Major liver disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Universidade do Vale do Itajaí-UNIVALI / Santa Catarina

Itajaí, Santa Catarina, Brazil

WITHDRAWN

Faculdade de Medicina de Botucatu -UNESP

Botucatú, São Paulo, 18607-621, Brazil

ACTIVE NOT RECRUITING

Clinical Hospital of São Paulo University

São Paulo, São Paulo, 05403-010, Brazil

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

5ml of plasm

MeSH Terms

Conditions

Crohn DiseaseThrombosis

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Andre ZA Leite, MD

    Clinical Hospital of São Paulo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andre ZA Leite, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2015

First Posted

May 15, 2015

Study Start

May 1, 2015

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

May 12, 2016

Record last verified: 2015-05

Locations